These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35657750)

  • 21. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D
    Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19-Related Cholangiopathy: Histological Findings.
    Borges VFA; Cotrim HP; Andrade ARCF; Mendes LSC; Penna FGC; Silva MC; Salomão FC; Freitas LAR
    Diagnostics (Basel); 2024 Aug; 14(16):. PubMed ID: 39202292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratin 7 expression in hepatic cholestatic diseases.
    Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
    Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in liver stiffness using acoustic radiation force impulse imaging in patients with obstructive cholestasis and cholangitis.
    Attia D; Pischke S; Negm AA; Rifai K; Manns MP; Gebel MJ; Lankisch TO; Potthoff A
    Dig Liver Dis; 2014 Jul; 46(7):625-31. PubMed ID: 24666759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome in a child: diagnostic usefulness of magnetic resonance cholangiopancreatography.
    Lee WS; Saw CB; Sarji SA
    J Paediatr Child Health; 2005 Apr; 41(4):225-7. PubMed ID: 15813880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19-associated secondary sclerosing cholangitis with liver transplantation.
    Fischer AK; Stippel D; Canbay A; Nierhoff D; Thomas M; Best J; Büttner R; Drebber U
    Virchows Arch; 2024 Aug; 485(2):371-377. PubMed ID: 38526652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributing factors and outcomes of burn-associated cholestasis.
    de Tymowski C; Dépret F; Soussi S; Nabila M; Vauchel T; Chaussard M; Benyamina M; Ferry A; Cupaciu A; Jully M; Oueslati H; Fratani A; Coutrot M; Sogni P; Mimoun M; Chaouat M; Zagdanski AM; De Kerviler E; Mebazaa A; Moreau R; Mallet V; Legrand M;
    J Hepatol; 2019 Sep; 71(3):563-572. PubMed ID: 31152758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary Sclerosing Cholangitis due to Gallbladder Adenocarcinoma.
    Fan DS; Sorser SA; Gamarra RM
    Case Rep Gastroenterol; 2013 Jan; 7(1):134-9. PubMed ID: 23626514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.
    Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP
    Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of primary sclerosing cholangitis.
    Harrison PM
    J Hepatobiliary Pancreat Surg; 1999; 6(4):356-60. PubMed ID: 10664281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-COVID cholangiopathy: A narrative review.
    Caballero-Alvarado J; Zavaleta Corvera C; Merino Bacilio B; Ruiz Caballero C; Lozano-Peralta K
    Gastroenterol Hepatol; 2023; 46(6):474-482. PubMed ID: 36174796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overlap syndrome: autoimmune sclerosing cholangitis.
    Thakker A; Karande S
    Indian Pediatr; 2010 Dec; 47(12):1063-5. PubMed ID: 21220805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
    Nguyen L; Cazzagon N; Corpechot C; El Mouhadi S; Lemoinne S; Chazouillères O; Arrivé L
    Eur Radiol; 2019 Mar; 29(3):1460-1468. PubMed ID: 30159619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary Sclerosing Cholangitis due to Severe COVID-19: An Emerging Disease Entity?
    Seifert M; Kneiseler G; Dechene A
    Digestion; 2023; 104(4):306-312. PubMed ID: 36889285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholestatic liver disease. Recognizing the clinical signs.
    Bhatia AS; Mihas AA
    Postgrad Med; 2006; 119(1):67-75, 82. PubMed ID: 16913649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis.
    Ghafoor S; Germann M; Jüngst C; Müllhaupt B; Reiner CS; Stocker D
    Insights Imaging; 2022 Aug; 13(1):128. PubMed ID: 35939241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary sclerosing cholangitis.
    Lefkowitch JH
    Arch Intern Med; 1982 Jun; 142(6):1157-60. PubMed ID: 7092426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic dilatation of intrahepatic bile ducts in primary sclerosing cholangitis.
    Genève J; Dubuc N; Mathieu D; Zafrani ES; Dhumeaux D; Métreau JM
    J Hepatol; 1990 Sep; 11(2):196-9. PubMed ID: 2254629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune Hepatitis Overlap Syndromes and Liver Pathology.
    Czaja AJ; Carpenter HA
    Gastroenterol Clin North Am; 2017 Jun; 46(2):345-364. PubMed ID: 28506369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.